I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.
PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.
The market sold off on Thursday after close as big hitters, including Amazon, reported earnings.
We already know that the Fed is going to take all necessary measures to support the economy.
I'm long GILD, but the fact is that the firm is not trying to make money off of Remdesivir at this point.
PFE's charts are constructive and traders could go long at current levels.
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
India's drugmakers aim to manufacture generic versions of any coronavirus 'cure', even before the full findings as to how effective they are.
More government funding is approved to fight Covid-19 layoffs, Gilead sells off on early reports around China trials and Intel announces earnings.
Let's take a look at the charts and indicators.